Variant · Snv
TP53 S241F
CI-VAR-00004033Explore in graph →CIViC 2777
Curated evidence
Evidence by cancer (2 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 11896595
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Unmapped disease2unmapped disease | ||||||||
| TP53 S241F | (functional) | Functional | D | Supports Dominant Negative | 3 | accepted | EID10250A set of previously characterized p53 mutants was tested in the yeast assay to understand their transdominant potential (dominant negative). Each mutant was expressed equally with the wild-type p53. T… (full text at CIViC) PMID 11896595 · Monti et al., 2002 · Open in CIViC | civic |
| TP53 S241F | (functional) | Functional | E | Supports Loss Of Function | 4 | submitted | EID7501The S241F mutation, which is a tumor-associated tumor, is found within DLD-1 cells. S241 mutations in p53 were seen to reduce the binding of BARD1 and CstF which disrupts the CstF/BARD1/p53 complex as… (full text at CIViC) PMID 21383700 · Nazeer et al., 2011 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available